Product
IVIG
Aliases
Shu Yang IVIG
4 clinical trials
6 indications
Indication
Primary Immunodeficiency DiseaseIndication
Long COVIDIndication
Long Covid-19Indication
Long COVID-19Indication
COVID-19Indication
Hemorrhagic Fever with Renal SyndromeClinical trial
Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG in Patients With Primary ImmunodeficiencyStatus: Not yet recruiting, Estimated PCD: 2025-01-08
Clinical trial
RECOVER-AUTONOMIC: A Platform Protocol for Evaluation of Interventions for Autonomic Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)Status: , Estimated PCD: 2025-12-01
Clinical trial
RECOVER-AUTONOMIC (IVIG): Randomized Trial of the Effect of IVIG Versus Placebo on Long COVID SymptomsStatus: , Estimated PCD: 2025-12-01
Clinical trial
Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Multicenter, Prospective, Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2024-06-30